id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0102-0011,FDA,FDA-2003-N-0102,Pennfield Oil Company - Withdrawal,Other,WDL-Withdrawal,2009-08-10T04:00:00Z,2009,8,2009-08-10T04:00:00Z,,2009-08-10T22:10:20Z,,0,0,0900006480a0505b
FDA-2003-N-0102-0010,FDA,FDA-2003-N-0102,HF-1,Other,LET-Letter,2005-01-25T05:00:00Z,2005,1,,,2008-04-12T00:58:36Z,,0,0,090000648048413e
FDA-2003-N-0102-0009,FDA,FDA-2003-N-0102,HF-1,Other,LET-Letter,2004-07-14T04:00:00Z,2004,7,,,2008-04-12T00:58:37Z,,0,0,090000648048413b
FDA-2003-N-0102-0008,FDA,FDA-2003-N-0102,"The Honorable Elizabeth Dole, et al to the Food and Drug Administration - Letter",Other,LET-Letter,2004-05-04T04:00:00Z,2004,5,,,2009-08-10T22:43:14Z,,0,0,0900006480484139
FDA-2003-N-0102-0007,FDA,FDA-2003-N-0102,The Honorable Lee Terry to the Center for Veterinary Medicine - Letter,Other,LET-Letter,2004-05-04T04:00:00Z,2004,5,,,2009-08-10T22:40:01Z,,0,0,0900006480484137
FDA-2003-N-0102-0003,FDA,FDA-2003-N-0102,Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing; Correction,Notice,NCR-Notice of Correction,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-11-07T04:59:59Z,2009-08-10T22:30:15Z,,0,0,09000064804840c3
FDA-2003-N-0102-0005,FDA,FDA-2003-N-0102,FDA Office of Chief Counsel to Dockets Management Branch - Separation of Functions,Other,SF-Separation of Functions,2003-12-12T05:00:00Z,2003,12,,,2009-08-10T22:37:24Z,,0,0,09000064804840c8
FDA-2003-N-0102-0001,FDA,FDA-2003-N-0102,Certain Antibiotic New Animal Drug Products and Use Combinations Subject to Listings in New Animal Drug Regulations; Notice of Opportunity for Hearing,Notice,NPH-Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-09-09T03:59:59Z,2009-08-10T22:27:34Z,,0,0,090000648048405a
FDA-2003-N-0102-0002,FDA,FDA-2003-N-0102,See FDA-2003-N-0102-0001,Notice,NPH-Notice of Opportunity of Hearing,2003-12-12T05:00:00Z,2003,12,2003-08-05T04:00:00Z,2003-09-09T03:59:59Z,2009-08-10T22:32:45Z,,0,0,09000064804840a6
FDA-2003-N-0102-0004,FDA,FDA-2003-N-0102,FDA/CVM Response to Buchanan Ingersoll - Letter,Other,LET-Letter,2003-12-12T05:00:00Z,2003,12,,,2009-08-10T22:38:25Z,,0,0,09000064804840c6